- Browse
- Shinya Yamanaka
- Okita et al
- pCXLE-EGFP
- Citations
pCXLE-EGFP Citations (54)
Originally described in: A more efficient method to generate integration-free human iPS cells.Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka KI, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S Nat Methods. 2011 May;8(5):409-12 PubMed Journal
Articles Citing pCXLE-EGFP
Showing 1 to 10 of 54 entries
Articles |
---|
Articles |
---|
Non-canonical isoforms of the mRNA polyadenylation factor WDR33 regulate STING-mediated immune responses. Liu L, Manley JL. Cell Rep. 2024 Mar 26;43(3):113886. doi: 10.1016/j.celrep.2024.113886. Epub 2024 Mar 1. PubMed |
Targeted viral adaptation generates a simian-tropic hepatitis B virus that infects marmoset cells. Liu Y, Cafiero TR, Park D, Biswas A, Winer BY, Cho CH, Bram Y, Chandar V, Connell AKO, Gertje HP, Crossland N, Schwartz RE, Ploss A. Nat Commun. 2023 Jun 16;14(1):3582. doi: 10.1038/s41467-023-39148-3. PubMed |
Comparison of vector elements and process conditions in transient and stable suspension HEK293 platforms using SARS-CoV-2 receptor binding domain as a model protein. Green EA, Hamaker NK, Lee KH. BMC Biotechnol. 2023 Mar 7;23(1):7. doi: 10.1186/s12896-023-00777-7. PubMed |
Biofabrication of synthetic human liver tissue with advanced programmable functions. Florentino RM, Morita K, Haep N, Motomura T, Diaz-Aragon R, Faccioli LAP, Collin de l'Hortet A, Cetin Z, Frau C, Vernetti L, Amler AK, Thomas A, Lam T, Kloke L, Takeishi K, Taylor DL, Fox IJ, Soto-Gutierrez A. iScience. 2022 Nov 4;25(12):105503. doi: 10.1016/j.isci.2022.105503. eCollection 2022 Dec 22. PubMed |
Generation of transgene-free human induced pluripotent stem cells from erythroblasts in feeder-free conditions. Perriot S, Canales M, Mathias A, Du Pasquier R. STAR Protoc. 2022 Aug 17;3(3):101620. doi: 10.1016/j.xpro.2022.101620. eCollection 2022 Sep 16. PubMed |
Generation of human induced pluripotent stem cell line EURACi006-A and its isogenic gene-corrected line EURACi006-A-1 from an arrhythmogenic cardiomyopathy patient carrying the c.1643delG PKP2 mutation. Meraviglia V, Ganesh S, Arendzen CH, Freund C, Sommariva E, Rossini A, Bellin M. Stem Cell Res. 2021 Jul;54:102426. doi: 10.1016/j.scr.2021.102426. Epub 2021 Jun 8. PubMed |
Non-viral derivation of a transgene-free induced pluripotent stem cell line from a male beagle dog. Yoshimatsu S, Edamura K, Yoshii Y, Iguchi A, Kondo H, Shibuya H, Sato T, Shiozawa S, Okano H. Stem Cell Res. 2021 May;53:102375. doi: 10.1016/j.scr.2021.102375. Epub 2021 Apr 29. PubMed |
Generation of two induced pluripotent stem cell lines from patients with X-linked Alport syndrome. Ma Y, Wang Z, Gao M, Liu X, Sun W, Gong Y, Sun G, Liu G. Stem Cell Res. 2021 May;53:102343. doi: 10.1016/j.scr.2021.102343. Epub 2021 Apr 17. PubMed |
Establishment of an iPSC line (CSUXHi004-A) from a patient with Waardenburg syndrome type I caused by a PAX3 splice mutation. Wen J, He C, Feng Y, Song J, Liu J, Liu X, Mei L, Ling J, Chen H, Liu Y. Stem Cell Res. 2021 May;53:102300. doi: 10.1016/j.scr.2021.102300. Epub 2021 Mar 18. PubMed |
Monitoring Axonal Degeneration in Human Pluripotent Stem Cell Models of Hereditary Spastic Paraplegias. Li XJ, Mou Y, Milton C, Chen Z. Methods Mol Biol. 2021 Mar 27. doi: 10.1007/7651_2021_379. PubMed |
If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.